CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,645 · Q3 • database Scopus / SJR & Web of Science indexed
Advances in Rheumatology
United Kingdom · BioMed Central Ltd
workspace_premium Q3 — Rheumatology verified Plan S Compliant visibility_off Double blind peer review lock_open Open Access

Advances in Rheumatology

Advances in Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 43. It is an CC BY Journal with a Double blind peer review review system The scope of the journal is focused on rheumatology, rheumatic diseases. It has an SJR impact factor of 0,645 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,645.

Publisher: BioMed Central Ltd
Category: Rheumatology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,645 Q3
H-index 43
Acceptance rate pie_chart
35%
Source Acceptance_Rate
Time to publication hourglass_top
53 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
0 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,645

H-index

43

Docs (year)

91

Docs 3y

174

Total refs

3934

Cites 3y

380

Citable 3y

170

Cites/Doc 2y

1.9

Ref/Doc

43.23

Immediate OA

0 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Advances in Rheumatology?

Advances in Rheumatology has an SJR of 0,645 (best quartile Q3) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 0 EUR.

What is the acceptance rate?

The acceptance rate recorded for Advances in Rheumatology is 35%.